Skip to content

Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms

Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for Patients With Pancreatic and Periampullary Neoplasms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05225038
Enrollment
23
Registered
2022-02-04
Start date
2022-06-13
Completion date
2023-10-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Neoplasms, Periampullary Carcinoma

Brief summary

Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for participants with Pancreatic and Periampullary Neoplasms

Detailed description

Frailty is independently associated with an increased risk of adverse outcomes after major surgery, including pancreatic resection. Prehabilitation aims to optimize modifiable risk factors to improve participants' baseline health prior to surgery. Multiple studies with participants undergoing pancreatic surgery have investigated the impact of prehabilitation on preoperative health metrics as well as postoperative outcomes. The majority of these studies focused only on exercise; if nutritional and/or psychological status were assessed, these dimensions were not intervened upon in prehabilitation regimens or reassessed postoperatively. This randomized controlled trial (RCT) is designed to assess the impact of physical and nutritional prehabilitation on participants' perioperative condition for those undergoing pancreatic resection for diagnosed or suspected pancreatic and periampullary neoplasms.

Interventions

OTHERExercise

Participants will meet with an exercise physiologist to undergo evaluation and develop individualized regimens for prehabilitation.

DIETARY_SUPPLEMENTNutritional

Participants will meet with a nutritionist to undergo evaluation and develop individualized regimens for prehabilitation.

BEHAVIORALBehavioral Medicine

Participants will have 1 appointment with behavioral medicine - all participants will meet with the same behavioral medicine specialist to ensure consistency. Participants will receive education regarding factors that affect postoperative recovery and relaxation techniques. Participants will also have the option to request faith support.

BEHAVIORALSmoking Cessation

Participants who are actively smoking will be counseled regarding smoking cessation during their preoperative appointment with a member of the surgical team. They will also be offered a referral to smoking cessation resources.

Sponsors

Case Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants \> 18 years old with ECOG performance status 0-2 and ASA score ≤3 * Requiring pancreatic resection for diagnosed or suspected pancreatic and periampullary neoplasms * Surgery scheduled at least 2 weeks after the initial surgical evaluation * Fluency in English * Willingness to answer questionnaires, complete daily exercise & nutrition log, as well as participate in follow-up telephone calls * Screening: Physical Activity Readiness - Questionnaire (PAR-Q+) * PAR-Q+ assesses participants comorbidities and symptoms with current activities. If participants answer yes to any of the screening questions, they will need to complete additional questions regarding their chronic medical conditions including, but not limited to, heart disease, stroke, diabetes, depression/anxiety, and COPD/asthma, to determine their ability to participate in physical activity.

Exclusion criteria

* Screening: Physical Activity Readiness - Questionnaire (PAR-Q+) * Participants with concurrent medical conditions that prohibit exercise, such as those who indicate on the questionnaire that they experience chest pain, dizziness, or loss of consciousness with physical activity; those with chest pain at rest; or those with bone/joint/soft tissue conditions that could worsen with physical activity. Participants with specific comorbidities, such as coronary artery disease. congestive heart failure, or uncontrolled asthma/COPD, that may prevent participation will also be excluded. * Inability to provide own informed consent * Inability to read or verbally understand questionnaires in English * Impaired hearing that creates a barrier for telephone follow-up * Visual deficit that would cause exercise to be hazardous * Emergent or urgent surgeries

Design outcomes

Primary

MeasureTime frameDescription
Change in participants physical capacity, as represented by hand grip strength3 weeks after the surgeryPrevious studies have demonstrated that grip strength is a predictor of surgical outcomes and mortality in cancer participants. Grip strength will be measured utilizing the Jamar Dynamometer.

Secondary

MeasureTime frameDescription
Mortality RateUp to 90 days after the surgeryDeath due to any cause postoperatively.
Morbidity rateUp to 90 days after the surgeryClassified according to the Clavien-Dindo Classification of postoperative complications.
Physical capacity as represented by 30s CST (Chair Stand Test )3 weeks after the surgeryParticipants rise to full standing position from sitting in a chair as many times as possible within 30 seconds. The 30s CST has been utilized as a reliable test of lower extremity strength.
Physical capacity as represented by 6-Minute Walk Test3 weeks after the surgeryParticipants will walk as far as possible in 6 min at a comfortable pace but do not run or jog. If participants cannot complete the full 6 min walk, then record the time and distance walked and the reason for stopping early.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026